| Predicate |
Object |
| contentType |
Journal Article |
| endingPage |
1460 |
| issn |
1387-2877
1875-8908 |
| issueIdentifier |
4 |
| pageRange |
1457-1460 |
| publicationName |
Journal of Alzheimer's disease : JAD |
| startingPage |
1457 |
| bibliographicCitation |
Høilund-Carlsen PF, Alavi A. Aducanumab (Marketed as Aduhelm) Approval Is Likely Based on Misinterpretation of PET Imaging Data. J Alzheimers Dis. 2021;84(4):1457–60. doi: 10.3233/jad-215275. PMID: 34657891. |
| creator |
http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0001-7420-2367
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_711c471488ed0c6a1fa4f5660bd057c9 |
| date |
2021-12-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| identifier |
https://pubmed.ncbi.nlm.nih.gov/34657891
https://doi.org/10.3233/jad-215275 |
| isPartOf |
http://rdf.ncbi.nlm.nih.gov/pubchem/journal/21942
https://portal.issn.org/resource/ISSN/1875-8908
https://portal.issn.org/resource/ISSN/1387-2877 |
| language |
English |
| source |
https://www.crossref.org/
https://pubmed.ncbi.nlm.nih.gov/ |
| title |
Aducanumab (Marketed as Aduhelm) Approval Is Likely Based on Misinterpretation of PET Imaging Data |
| discusses |
http://id.nlm.nih.gov/mesh/M0556300
http://id.nlm.nih.gov/mesh/M000608738 |
| hasPrimarySubjectTerm |
http://id.nlm.nih.gov/mesh/D058225Q000378
http://id.nlm.nih.gov/mesh/D061067Q000627
http://id.nlm.nih.gov/mesh/D049268
http://id.nlm.nih.gov/mesh/D003627
http://id.nlm.nih.gov/mesh/D000544Q000188 |
| hasSubjectTerm |
http://id.nlm.nih.gov/mesh/D017277
http://id.nlm.nih.gov/mesh/D006801
http://id.nlm.nih.gov/mesh/D014486
http://id.nlm.nih.gov/mesh/D014481 |
| discussesAsDerivedByTextMining |
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID11262
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID6852 |